Skin Vaccination Summit 2013

4-6 September, Bell Harbor Conference Centre, Seattle, Washington, USA

  • Increase font size
  • Default font size
  • Decrease font size

Day Three

Final Conference Programme | Friday 6th September

SESSION 9:
DISEASE AND PATHOGEN TARGETED FOR CUTANEOUS VACCINATION I

Moderator: Steve Reed (IDRI, Seattle, Washington, USA)

09.00-09.30
‘Transcutaneous immunization with a patch resolves active experimental otitis media’
Laura A. Novotny, Kathleen A. Stuller, John D. Clements and Lauren O. Bakaletz (The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, USA)

09.30-09.50
‘Measles vaccination of non-human primates using a microneedle patch’
Chris Edens, M.L. Collins, J. Goodson, P.A. Rota and M.R. Prausnitz (Georgia Institute of Technology, Atlanta, Georgia, USA)

09.50-10.10
‘Skin immunization against rotavirus using microneedles’
Baoming Jiang (Centers for Disease Control, Atlanta, Georgia, USA)

10.10-10.40
Coffee Break & Posters

SESSION 10:
DISEASE AND PATHOGEN TARGETED FOR CUTANEOUS VACCINATION II

Moderator: Steve Reed (IDRI, Seattle, Washington, USA)

10.40-11.10
‘Needle-free, cutaneous jet injection of reduced-dose, influenza vaccine in >= 6 to < 24-month-old children’
Bruce G. Weniger (Chiang Mai University, Chiang Mai, Thailand), and the Jet-Injected Cutaneous Influenza Vaccination Study Group)

11.10-11.40
‘Alternative intradermal administration methods for BCG and novel TB vaccines’
Hennie Geldenhuys (University of Cape Town, Cape Town, South Africa)

11.40-12.00
‘Assessment of dose-sparing of pandemic, monovalent A/California/7/2009 H1N1 influenza vaccine administered intradermally by needle-free disposable-syringe jet injector (DSJI)’
Glacus de Souza Brito (Faculdade de Medicina da USP, University of Sao Paulo, Sao Paulo, Brazil)

12.00-13.30
Lunch Break & Posters Breakdown

SESSION 11:
OPEN FORUM: THE FUTURE OF SKIN

13.30-15.00
PANEL & AUDIENCE

Moderator: Bruce G. Weniger (Chiang Mai University, Chiang Mai, Thailand)

Panel Members:
Mark Prausnitz (Georgia Institute of Technology, Atlanta, Georgia, USA)
Darin Zehrung (PATH, Seattle, Washington, USA)
Mark A.F. Kendall (University of Queensland, Brisbane, Queensland, Australia)
Nathalie Garcon (GSK Biologicals, Rixensart, Belgium)
John Clements (Tulane University, New Orleans, Louisiana, USA)

Closing Remarks
Bruce G. Weniger (Chiang Mai University, Chiang Mai, Thailand)

15.00
Conference Close & Departure

* This final programme is correct at the time of printing. However the organisers reserve the right to make any alterations that may be required in the interests and integrity of the final programme.

 

SVS 2013 Delegates

Login details will be supplied after you have registered for the event.


SVS 2013 Sponsors

  • PharmaJet
  • Infectious Disease Research Institute
  • Bioject
  • Nature Gene Therapy
  • Novartis Vaccines
  • Univac
  • Corium
  • 3M
  • Becton Dickinson
  • Path
  • Aldevron
  • Current Drug Delivery
  • DNA Vaccine
  • Debiotech
  • Drug Delivery Letters
  • ONdrugDELIVERY
  • Inovio Pharmaceuticals
  • NanoPass
  • Star Syringe
  • Zoetis
  • West
  • Sanaria
  • Sanofi Pasteur

SVS 2013 Downloads

SVS 2013 Leaflet

SVS 2013 Mailing List

Name
E-mail Address
What is 1+4-2?